Diers Biomedical Solutions Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 3.44 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 416.21%
- Profit Growth 408.82%
- Ebitda 386.00%
- Net Worth 40.66%
- Total Assets 43.93%
About Diers Biomedical Solutions
Diers Biomedical Solutions Private Limited (DBSPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 23 August 2012 and has a history of 12 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.44 M, as per Ministry of Corporate Affairs (MCA) records.
Loretta Zircher, Karun Kunden, and Carsten Diers serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85190DL2012FTC240765
-
Company No.
240765
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
23 Aug 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Diers Biomedical Solutions Private Limited offer?
Diers Biomedical Solutions Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Physiotherapy Equipment.
Who are the key members and board of directors at Diers Biomedical Solutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karun Kunden
|
Whole-Time Director | 01-Apr-2019 | Current |
Carsten Diers
|
Director | 01-Aug-2019 | Current |
|
Loretta Zircher
|
Director | 20-Sep-2012 | Current |
Financial Performance of Diers Biomedical Solutions.
Diers Biomedical Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 416.21% increase. The company also saw a substantial improvement in profitability, with a 408.82% increase in profit. The company's net worth Soared by an impressive increase of 40.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diers Biomedical Solutions?
In 2023, Diers Biomedical Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diers Biomedical Solutions?
Unlock and access historical data on people associated with Diers Biomedical Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diers Biomedical Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diers Biomedical Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
